Gaurav Shah

Insider Reports History

Entity
Individual
Location
430 East 29 Th Street, Suite 1040, New York, New York
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gaurav Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. CEO, Director Common Stock 718K $13.3M $18.50 Aug 16, 2024 Direct
ROCKET PHARMACEUTICALS, INC. CEO, Director Common Stock 208K $3.85M $18.50 Aug 16, 2024 By Spouse
ROCKET PHARMACEUTICALS, INC. CEO, Director Common Stock 198K $3.67M $18.50 Aug 16, 2024 By Gaurav D. Shah Irrevocable Trust
ROCKET PHARMACEUTICALS, INC. CEO, Director Stock Option (Right to Buy) 196K $2.46M $12.55 Feb 16, 2024 Direct
ROCKET PHARMACEUTICALS, INC. CEO, Director Restricted Stock Units 77.5K $2.11M $27.20 Feb 14, 2024 Direct
Talaris Therapeutics, Inc. Director Stock Option (Right to Buy) 20.5K Jun 13, 2023 Direct

Insider Reports Filed by Gaurav Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCKT ROCKET PHARMACEUTICALS, INC. Aug 16, 2024 1 -$179K 4 Aug 20, 2024 CEO, Director
RCKT ROCKET PHARMACEUTICALS, INC. May 14, 2024 9 -$229K 4 May 20, 2024 CEO, Director
RCKT ROCKET PHARMACEUTICALS, INC. Feb 16, 2024 3 -$605K 4 Feb 21, 2024 CEO, Director
RCKT ROCKET PHARMACEUTICALS, INC. Feb 14, 2024 3 $0 4 Feb 16, 2024 CEO, Director
RCKT ROCKET PHARMACEUTICALS, INC. Nov 14, 2023 2 $0 4 Nov 16, 2023 CEO, Director
RCKT ROCKET PHARMACEUTICALS, INC. Aug 17, 2023 1 -$73.8K 4 Aug 21, 2023 CEO, Director
RCKT ROCKET PHARMACEUTICALS, INC. Aug 14, 2023 2 $0 4 Aug 15, 2023 CEO, Director
TALS Talaris Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 14, 2023 Director
RCKT ROCKET PHARMACEUTICALS, INC. May 17, 2023 1 -$88.1K 4 May 19, 2023 CEO, Director
RCKT ROCKET PHARMACEUTICALS, INC. May 14, 2023 2 $0 4 May 16, 2023 CEO, Director
RCKT ROCKET PHARMACEUTICALS, INC. Feb 17, 2023 1 -$232K 4 Feb 22, 2023 CEO, Director
RCKT ROCKET PHARMACEUTICALS, INC. Feb 14, 2023 4 $0 4/A Feb 22, 2023 CEO, Director
TALS Talaris Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
RCKT ROCKET PHARMACEUTICALS, INC. Feb 14, 2022 2 $0 4 Feb 16, 2022 CEO, Director
RCKT ROCKET PHARMACEUTICALS, INC. Feb 7, 2022 1 $382K 4 Feb 8, 2022 CEO, Director